Therapeutic Asset Ratings
181 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
BLOOD, WHOLE
Non-Small Cell Lung Carcinoma
Paradigm Health
D
(28)
HUMAN PERIPHERAL BLOOD LEUKOCYTES
Non-Small Cell Lung Carcinoma
A2 Biotherapeutics Inc.
D
(28)
Bbp-398
Non Small Cell Lung Cancer
LianBio LLC
P1
D
(22)
Nanocrystalline Megestrol
Non-Small Cell Lung Carcinoma
Hunan Province Tumor Hospital
P3
NR
(0)
Adibelimab
Non-Small Cell Lung Carcinoma
Second Affiliated Hospital of Xi'an Jiaotong University
P2
NR
(0)
Efgbemalenograstim Alfa
Non-Small Cell Lung Carcinoma
Tianjin Medical University Cancer Institute and Hospital
P2
NR
(0)
Showing 176 to 181 of 181 assets
Previous
Page 8 of 8
Next